Suggest Edits

Be The First To
Add Photos

Headquarters Berkeley, CA
Size 150 to 499 Employees
Founded Unknown
Type Company - Public (DVAX)
Industry Biotech & Pharmaceuticals
Revenue ₹500 million to ₹1 billion (INR) per year

Dynavax Technologies is trying to reprogram the way the body reacts to disease. The firm focuses on immunostimulatory sequences (ISS), short strands of DNA found to strengthen the immune system. The company's lead candidate in clinical trials is HEPLISAV, a hepatitis B vaccine. Other candidates in the company's pipeline include a universal flu vaccine that would cover a wider span of flu viruses than traditional flu vaccines, as well as potential treatments for asthma, hepatitis C, and autoimmune and inflammatory diseases. To share the expense and risk of development... More

Working at Dynavax Technologies

Posted by employees

Employees say it's “OK”   4 ratings


34% Approve of the CEO   3 ratings

(no image)

Dino Dina

President, CEO, and Director

Great place to work

  Former Employee

Pros: Great product, not hard to sale, implement and train customer. Full Review

More Dynavax Technologies Ratings & Reviews ( 4)

Accepted Offer – Interviewed in Berkeley, CA (US) Dec 2011 – Reviewed Oct 17, 2012

Interview Details I submitted my resume on-line; was contacted by the HR Representative; went in for face to face interviews; met with various department heads;Full Interview

Interview Question:
Please try to be as detailed as possible regarding the technical question, business case, etc. Answer Question

More Dynavax Technologies Interview Questions & Reviews (1)

Dynavax Technologies Awards and Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Worked for Dynavax Technologies? Contribute to the Community!